US 12,441,714 B2
Pyrrolidine compounds
Celia Lafuente Blanco, San Sebastian de los Reyes (ES); Nuria Diaz Buezo, Madrid (ES); Jose Antonio Martinez Perez, Madrid (ES); Gema Consuelo Sanz Gil, Madrid (ES); and Julian Priego Soler, Madrid (ES)
Assigned to ELI LILLY AND COMPANY, Indianapolis, IN (US)
Filed by Eli Lilly and Company, Indianapolis, IN (US)
Filed on Feb. 15, 2022, as Appl. No. 17/671,806.
Application 17/671,806 is a continuation of application No. 17/056,144, granted, now 11,286,249, previously published as PCT/US2020/035825, filed on Jun. 3, 2020.
Claims priority of application No. 19382477 (EP), filed on Jun. 7, 2019.
Prior Publication US 2022/0169636 A1, Jun. 2, 2022
Int. Cl. C07D 207/06 (2006.01); C07D 403/14 (2006.01)
CPC C07D 403/14 (2013.01) [C07D 207/06 (2013.01)] 5 Claims
 
1. A compound of the formula

OG Complex Work Unit Chemistry
wherein
Rb is H or CH3;
Re is H or a protecting group;
Rf is H or a protecting group;
Rd is selected from the group consisting of H, Br, CHO, CH2OH, OH, NH2, and NO2; or a pharmaceutically acceptable salt thereof.